The Unified Patent Court (UPC) is revolutionizing the way patents are enforced in Europe, and McDermott’s intellectual property (IP) team is here to help you navigate this dynamic landscape. Our Legal Lens on the Unified...more
The US Court of Appeals for the Federal Circuit affirmed a district court’s noninfringement determination, finding that the presence of a disclaimed compound in the accused product precluded infringement. Azurity Pharm., Inc....more
4/17/2025
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Claim Construction ,
Disclaimers ,
Doctrine of Prosecution Disclaimer ,
Generic Drugs ,
Hatch-Waxman ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents
The US Court of Appeals for the Federal Circuit denied a mandamus petition requesting transfer from the Marshall division to the Sherman division within the US District Court for the Eastern District of Texas, finding that...more
4/17/2025
/ Appeals ,
Appellate Courts ,
CAFC ,
Dismissals ,
Innovation Patent ,
Jurisdiction ,
Litigation Strategies ,
Motion to Transfer ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Venue